Invention Grant
- Patent Title: FXR agonists
- Patent Title (中): FXR激动剂
-
Application No.: US12296534Application Date: 2007-05-22
-
Publication No.: US07846960B2Publication Date: 2010-12-07
- Inventor: Michael Gregory Bell , Robert Anthony Doti , Michael James Genin , Peter Ambrose Lander , Tianwei Ma , Peter Rudolph Manninen , Jason Matthew Ochoada , Fucheng Qu , Lindsay Scott Stelzer , Ryan Edward Stites , Alan M. Warshawsky
- Applicant: Michael Gregory Bell , Robert Anthony Doti , Michael James Genin , Peter Ambrose Lander , Tianwei Ma , Peter Rudolph Manninen , Jason Matthew Ochoada , Fucheng Qu , Lindsay Scott Stelzer , Ryan Edward Stites , Alan M. Warshawsky
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Francis O. Ginah
- International Application: PCT/US2007/069445 WO 20070522
- International Announcement: WO2007/140183 WO 20071206
- Main IPC: A61K31/415
- IPC: A61K31/415 ; C07D231/10
Abstract:
Compounds of formula wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
Public/Granted literature
- US20090270460A1 FXR AGONISTS Public/Granted day:2009-10-29
Information query
